268 related articles for article (PubMed ID: 9712097)
41. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
Jelaska A; Korn JH
Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
[TBL] [Abstract][Full Text] [Related]
42. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells.
Tamm M; Bihl M; Eickelberg O; Stulz P; Perruchoud AP; Roth M
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):653-61. PubMed ID: 9761763
[TBL] [Abstract][Full Text] [Related]
44. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
45. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
46. Role of PDGF in fibrotic diseases and systemic sclerosis.
Trojanowska M
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v2-4. PubMed ID: 18784131
[TBL] [Abstract][Full Text] [Related]
47. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
[TBL] [Abstract][Full Text] [Related]
48. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
49. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
[TBL] [Abstract][Full Text] [Related]
50. Platelet-derived growth factor-AA increases IL-1beta and IL-8 expression and activates NF-kappaB in rheumatoid fibroblast-like synoviocytes.
Cheon H; Sun YK; Yu SJ; Lee YH; Ji JD; Song GG; Lee JH; Kim MK; Sohn J
Scand J Immunol; 2004 Nov; 60(5):455-62. PubMed ID: 15541037
[TBL] [Abstract][Full Text] [Related]
51. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
Galindo M; Santiago B; Rivero M; Rullas J; Alcami J; Pablos JL
Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
[TBL] [Abstract][Full Text] [Related]
52. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro.
Del Galdo F; Jiménez SA
Arthritis Rheum; 2007 Oct; 56(10):3478-88. PubMed ID: 17907195
[TBL] [Abstract][Full Text] [Related]
53. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.
Feghali CA; Bost KL; Boulware DW; Levy LS
J Rheumatol; 1992 Aug; 19(8):1207-11. PubMed ID: 1404155
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis.
Zurita-Salinas CS; Richaud-Patin Y; Krötzsch-Gómez E; Llorente L; Alcocer-Varela J; Díaz-de-León L; Palacios-Boix A
Rev Invest Clin; 1998; 50(2):97-104. PubMed ID: 9658927
[TBL] [Abstract][Full Text] [Related]
56. [Pathogenesis of systemic scleroderma: immunological aspects].
Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
[TBL] [Abstract][Full Text] [Related]
57. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
58. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
[TBL] [Abstract][Full Text] [Related]
59. Induction of PDGF-B in TCA-treated epidermal keratinocytes.
Yonei N; Kanazawa N; Ohtani T; Furukawa F; Yamamoto Y
Arch Dermatol Res; 2007 Nov; 299(9):433-40. PubMed ID: 17724602
[TBL] [Abstract][Full Text] [Related]
60. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]